6J Biotechnology  

anti-metastatic drugs development based on endolysosomal trafficking

OWNER

Qingru Zhang (See Profile)

Sector

Cancer therapeutics

Stage

Prototyping, preclinical

Country

United States


First-in-class broad-spectrum anti-metastasis oral drugs

Global patented technology with no competitors yet

can effectively inhibit tumor progression and metastasis with little toxicity and combinate therap with PD-L1

This information is confidential, do not share or copy.

Under evaluation at least till: 28th October

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar